205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.57%
Negative net income growth while AVGO stands at 6.67%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
113.04%
Some yoy growth while AVGO is negative at -5657.14%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
75.47%
SBC growth well above AVGO's 22.22%. Michael Burry would flag major dilution risk vs. competitor’s approach.
173.20%
Slight usage while AVGO is negative at -73.13%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
121.57%
AR growth well above AVGO's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
126.19%
Some inventory rise while AVGO is negative at -166.67%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
260.95%
Growth well above AVGO's 200.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-105.88%
Negative yoy while AVGO is 7900.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
80.35%
Some CFO growth while AVGO is negative at -15.14%. John Neff would note a short-term liquidity lead over the competitor.
30.07%
Some CapEx rise while AVGO is negative at -26.32%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
5.13%
Purchases growth of 5.13% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
199.82%
Liquidation growth of 199.82% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
-762.87%
Both yoy lines negative, with AVGO at -26.32%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
65.68%
Debt repayment at 50-75% of AVGO's 100.00%. Martin Whitman would worry about partial lag if competitor gains advantage from lower debt burdens.
-81.67%
Both yoy lines negative, with AVGO at -50.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
0.44%
Buyback growth of 0.44% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.